BOBCAT
Live / Registered — Registered (as of 20 May 2025)
What this means for you
Registered since 20 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98207353
- Registration number
- 7804750
- Mark type
- Stylized text
- Filed
- 03 Oct 2023
- Published for opposition
- 30 Jul 2024
- Registered
- 20 May 2025
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 20 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Apr 2025 — ASSIGNED TO LIE
- 10 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Apr 2025 — NON-FINAL ACTION E-MAILED
- 02 Apr 2025 — SU - NON-FINAL ACTION - WRITTEN
- 24 Mar 2025 — ASSIGNED TO EXAMINER
- 21 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Nov 2024 — USE AMENDMENT FILED